Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Clinical trial NCT03650764 · COMPLETED
Trial details
- NCT number
- NCT03650764
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-29
- Primary completion
- 2026-05-11
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.